|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 非维生素K拮抗与维生素K拮抗口服抗凝剂与脑出血患者住院死亡之间的关系显示文摘尽管非维生素K拮抗口服抗凝剂(non-vitamin K antagonist oral anticoagulants, NOACs)越来越多地应用于预防血栓栓塞性疾病,但关于NOACs相关性脑出血的数据仍然有限。 | 刘青 叶鹏 Inohara T Xian Y Liang L Matsouaka RA Saver JL Smith EE Schwamm LH Reeves MJ Hernandez AF Bhatt DL Peterson ED Fonarow GC | 2018 | 中华高血压杂志2018，26，2： | 16 |
| 2 | 溶栓时间(入院到用药时间)的延迟及其对脑卒中治疗时间与预后的影响显示文摘尽管美国心脏协会/美国脑卒中协会关于脑卒中的治疗均提出了倡议,大量急性缺血性脑卒中患者仍然在到达就诊60min后才开始启动组织型纤溶酶原激活剂(阿替普酶)溶栓治疗。该研究旨在描述延迟的原因及其与患者预后之间的关系。 | 刘莉 叶鹏 Kamal N Sheng S Xian Y Matsouaka R Hill MD Bhatt DL Saver JL Reeves MJ Fonarow GC Schwamm LH Smith EE | 2017 | 中华高血压杂志2017，25，4： | 15 |
| 3 | 缺血性脑卒中患者血压与住院临床结局的相关性显示文摘高血压是脑卒中的主要危险因素。研究表明,在缺血性脑卒中患者中,由于压力依赖性的脑血液流向缺血区域,脑卒中后高血压有益。然而,其他研究显示,脑卒中后的高血压与短期再发性脑卒中、脑出血性转化和脑水肿发生率升高有关。关于血压与脑卒中短期临床结局相关性的观察性研究结论相互矛盾。此外,关于血压的搏动组分(脉压)或稳定组分(平均动脉压)与临床结局相关性的数据有限。 | Bangalore S Schwamm L Smith EE Hellkamp AS Suter RE Xian Y Schulte PJ Fonarow GC Bhatt DL 练桂丽 叶鹏 | 2017 | 中华高血压杂志2017，25，11： | 5 |
| 4 | Racial and ethnie differences in outcomes in older patients with acute ischemic stroke 显示文摘 | Qian F Fonarnw GC Smith EE | 2013 | Cite Cardiovasc Qual Outcomes2013，6，3： | 1 |
| 5 | Characteristics, performance measures, and inhospital outcomes of the first one million stroke and transient ischemic attack admissions in get with the guidelines-stroke显示文摘 | Fonarow GC Reeves M J Smith EE | 2010 | Cire Cardiovasc Qual Outcomes2010，3，： | 1 |
| 6 | Characteristics, performance measures, and in- hospital outcomes of the first onemillion stroke and transient ischemic attack admissions in get with the guidelines-stroke显示文摘 | Fonarow GC Reeves M J Smith EE | 2010 | Circulation:Cite Cardiovasc Qual Outcomes2010，3，： | 1 |
| 7 | Characteristics, per- formance measures, and inhospital outcomes of the first one million stroke and transient ischemic attack admissions in get with the guidelines-stroke 显示文摘 | Fonarow GC Reeves MJ Smith EE | 2010 | Circ Cardiovasc Qual Out- comes2010，3，3： | 1 |
| 8 | The 'golden hour' and acute brain ischemia:presenting features and lytic therapy in >30,000 patients arriving within 60 minutes of stroke onset显示文摘 | Saver JL Smith EE Fonarow GC | 2010 | Stroke2010，41，： | 1 |
| 9 | Characteristics, performance measures, and inhospital outcomes of the first one million stroke and transient ischemic attack admissions in get with the guidelines-stroke显示文摘 | Fonarow GC Reeves MJ Smith EE | 2010 | Cire Cardiovasc Qual Outcomes2010，3，： | 1 |
| 10 | Ectoadenylate kinase and plasma membrane ATP synthase activities of human vascular endothelial cells显示文摘 | Quillen EE Haslam GC Samra HS | 2006 | J Biol Chem2006，281，20： | 1 |
| 11 | Outcomes in mild or rapidly improving stroke not treated with intravenous recombinant tissue-type plasminogen activator:findings from Get With The Guideline-Stroke显示文摘 | Smith EE Fonarow GC Reeves MJ | 2011 | Stroke2011，42，11： | 1 |
| 12 | Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke:patient characteristics, hospital factors, and outcomes associated with door-to- needle times within 60 minutes显示文摘 | Fonarow GC Smith EE Saver JL | 2011 | Circulation2011，123，： | 1 |
| 13 | Improving door-to-needle times in acute ischemic stroke:the design and rationale for the American Heart Association/American Stroke Association's Target:Stroke initiative显示文摘 | Fonarow GC Smith EE Saver JL | 2011 | Stroke2011，42，： | 1 |
| 14 | Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient char?acteristics, hospital factors, and outcomes associated with door-to?needle times within 60 minutes 显示文摘 | Fonarow GC Smith EE Saver JL | 2011 | Circulation2011，123，7： | 1 |
| 15 | Outcomes in mild or rapidly improving stroke not treated with intra- venous recombinant tissue-type plasminogen activator: findings from Get With The Guidelines-Stroke显示文摘 | Smith EE Fonarow GC Reeves MJ | 2011 | Stroke2011，42，11： | 1 |
| 16 | Relationship of National Institutes of Health Stroke Scale to 30-day mortality in medi- care beneficiaries with acute ischemic stroke显示文摘 | Fonarow GC Saver JL Smith EE | 2012 | J Am Heart As- soc2012，1，1： | 1 |
| 17 | Rho family proteins in cell adhesion and cell migration 显示文摘 | Evers EE Zondag Gc Mallin A | 2000 | Eur J Cancer2000，36，10： | 1 |
| 18 | Improving door-to-needle times in acute ischemic stroke: the design and rationale for the A?merican Heart Association! American Stroke Association's Target: Stroke initiative显示文摘 | Fonarow GC Smith EE Saver JL | 2011 | Stroke2011，42，10： | 1 |
| 19 | Outcomes in mild or rapidly improving stroke not treated with intravenous recombinant tissue -type plasminogen activator: findings from Get With The Guidelines - Stroke 显示文摘 | Smith EE Fonamw GC Reeves M J | 2011 | Stroke2011，42，11： | 1 |
| 20 | Outcomes in mild or rapidly knproving stroke not treated with intravenous recombinant tissue-type plasminogen activator: fardings from Get With The Guidelines-Stroke显示文摘 | Smith EE Fonarow GC Reeves MJ | 2011 | Stroke2011，42，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员